Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,953 | 13 | 43.3% |
| Consulting Fee | $27,148 | 14 | 31.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,900 | 5 | 10.4% |
| Travel and Lodging | $7,941 | 35 | 9.3% |
| Food and Beverage | $4,411 | 62 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aerie Pharmaceuticals, Inc. | $28,896 | 43 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $17,373 | 24 | $0 (2020) |
| Alcon Laboratories Inc | $16,906 | 20 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $9,701 | 9 | $0 (2019) |
| Sight Sciences, Inc. | $4,583 | 6 | $0 (2024) |
| Allergan, Inc. | $3,446 | 6 | $0 (2021) |
| Alcon Vision LLC | $2,579 | 6 | $0 (2024) |
| ABBVIE INC. | $1,411 | 7 | $0 (2024) |
| Glaukos Corporation | $340.83 | 5 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $101.19 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $575.30 | 6 | Alcon Vision LLC ($283.10) |
| 2023 | $5,904 | 12 | Sight Sciences, Inc. ($4,370) |
| 2022 | $2,413 | 5 | Alcon Vision LLC ($2,100) |
| 2021 | $4,758 | 7 | Aerie Pharmaceuticals, Inc. ($4,508) |
| 2020 | $8,766 | 9 | Aerie Pharmaceuticals, Inc. ($5,085) |
| 2019 | $14,904 | 24 | Aerie Pharmaceuticals, Inc. ($11,582) |
| 2018 | $25,205 | 39 | Bausch & Lomb, a division of Bausch Health US, LLC ($10,977) |
| 2017 | $22,826 | 27 | Alcon Laboratories Inc ($13,594) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $105.37 | General |
| Category: EYE CARE | ||||||
| 04/06/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $140.77 | General |
| Category: Ophthalmology | ||||||
| 03/01/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $76.44 | General |
| Category: Ophthalmology | ||||||
| 02/29/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $142.33 | General |
| Category: Ophthalmology | ||||||
| 02/29/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: Glaucoma | ||||||
| 01/17/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $95.73 | General |
| Category: EYE CARE | ||||||
| 11/10/2023 | ABBVIE INC. | DURYSTA (Drug), LUMIGAN, XEN GLAUCOMA TREATMENT SYSTEM | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: EYE CARE | ||||||
| 11/05/2023 | ABBVIE INC. | DURYSTA (Drug), LUMIGAN, XEN GLAUCOMA TREATMENT SYSTEM | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: EYE CARE | ||||||
| 08/17/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $76.21 | General |
| 08/17/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $73.28 | General |
| 05/31/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: Ophthalmology | ||||||
| 05/16/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: EYE CARE | ||||||
| 05/06/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $83.54 | General |
| Category: Ophthalmology | ||||||
| 05/05/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $87.95 | General |
| Category: Ophthalmology | ||||||
| 05/05/2023 | ABBVIE INC. | DURYSTA (Drug), XEN GLAUCOMA TREATMENT SYSTEM | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: EYE CARE | ||||||
| 04/18/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $90.95 | General |
| Category: Ophthalmology | ||||||
| 03/03/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: Ophthalmology | ||||||
| 01/19/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: EYE CARE | ||||||
| 05/20/2022 | Alcon Vision LLC | Simbrinza (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Ophthalmology | ||||||
| 04/22/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Ophthalmology | ||||||
| 03/28/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device) | Food and Beverage | Cash or cash equivalent | $164.18 | General |
| Category: GLAUCOMA | ||||||
| 03/25/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: GLAUCOMA | ||||||
| 03/03/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $96.25 | General |
| Category: Ophthalmology | ||||||
| 06/22/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $69.97 | General |
| Category: Glaucoma | ||||||
| 05/25/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,015.00 | General |
| Category: Glaucoma | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 3,265 | 4,358 | $1.5M | $243,477 |
| 2022 | 18 | 3,672 | 4,916 | $2.0M | $315,740 |
| 2021 | 16 | 3,530 | 4,634 | $1.6M | $285,672 |
| 2020 | 19 | 3,365 | 3,938 | $1.2M | $199,519 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 822 | 1,686 | $724,980 | $121,984 | 16.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 45 | 64 | $188,800 | $25,861 | 13.7% |
| 65820 | Incision to improve eye fluid flow | Office | 2023 | 22 | 27 | $99,360 | $20,092 | 20.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 738 | 759 | $94,116 | $15,980 | 17.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 751 | 775 | $96,875 | $13,010 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 257 | $74,787 | $12,137 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $57,652 | $8,865 | 15.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 22 | 22 | $34,152 | $6,250 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 85 | $36,550 | $5,474 | 15.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 13 | 18 | $20,862 | $3,065 | 14.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 68 | 126 | $17,780 | $2,835 | 15.9% |
| 92134 | Imaging of retina | Office | 2023 | 84 | 98 | $12,250 | $1,930 | 15.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 91 | 98 | $9,212 | $1,477 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 23 | $6,693 | $1,188 | 17.7% |
| 92025 | Ct scan of cornea | Office | 2023 | 69 | 80 | $7,200 | $1,183 | 16.4% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 50 | 52 | $6,448 | $1,098 | 17.0% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 51 | 53 | $6,625 | $783.30 | 11.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 43 | 43 | $1,892 | $263.64 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 818 | 1,707 | $734,167 | $122,566 | 16.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 58 | 82 | $241,900 | $32,981 | 13.6% |
| 65820 | Incision to improve eye fluid flow | Office | 2022 | 25 | 33 | $121,440 | $24,299 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 166 | 280 | $120,400 | $19,148 | 15.9% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Office | 2022 | 14 | 15 | $77,115 | $14,902 | 19.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 693 | 711 | $88,164 | $14,550 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 246 | 281 | $81,771 | $13,563 | 16.6% |
About Dr. Sameh Mosaed, MD
Dr. Sameh Mosaed, MD is a Ophthalmology healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275613432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameh Mosaed, MD has received a total of $85,352 in payments from pharmaceutical and medical device companies, with $575.30 received in 2024. These payments were reported across 129 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,953).
As a Medicare-enrolled provider, Mosaed has provided services to 13,832 Medicare beneficiaries, totaling 17,846 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Glaucoma Specialist
- Location Irvine, CA
- Active Since 10/16/2006
- Last Updated 01/23/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1275613432
Products in Payments
- VYZULTA (Drug) $17,274
- Rhopressa (Drug) $16,942
- SIMBRINZA (Biological) $9,131
- CyPass (Device) $8,165
- Centurion (Device) $8,058
- rocklatan (Drug) $5,141
- rhopressa (Drug) $4,452
- OMNI SURGICAL SYSTEM (Device) $4,446
- ALPHAGAN P (Drug) $3,196
- Rocklatan (Drug) $2,677
- Simbrinza (Drug) $2,100
- DURYSTA (Drug) $1,425
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $236.48
- ISTENT INJECT W (Device) $176.68
- OMNI(R) SURGICAL SYSTEM (US) (Device) $136.25
- LOTEMAX GEL (Drug) $101.19
- AcrySof (Device) $21.58
- Ophthalmic Surgical Adjuncts (Device) $15.10
- iDose (Device) $14.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Irvine
Baruch Kuppermann, Md, MD
Ophthalmology — Payments: $996,400
Dr. Marjan Farid, Md, MD
Ophthalmology — Payments: $673,334
Dr. Rhett Schiffman, Md, MD
Ophthalmology — Payments: $461,992
Dr. Mitul Mehta, Md, MD
Ophthalmology — Payments: $221,612
Dr. Andrew Browne, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $86,139
Dr. Vivek Patel, M.d, M.D
Ophthalmology — Payments: $75,541